Search clinical trials for: Abluminus Sirolimus Eluting Stent System (ASES)

Total 275 results

Cordis Corporation

Completed

Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Coronary Artery Disease

United States
Abbott Medical Devices

Completed

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Myocardial Ischemia | Coronary Artery Disease | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Stents | Total Coronary Occlusion | Coronary Artery Restenosis

United States
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
Cordis Corporation

Completed

Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (3D)

Coronary Artery Disease

Brazil
General Hospital of Chinese Armed Police Forces

Completed

Effect of TCFA on Neointimal Coverage After PCI at 9 Months Follow-up

Unrecognized Condition

China
Cordis Corporation

Completed

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

In-Stent Restenosis

United States
Biotyx Medical (Shenzhen) Co., Ltd.

Active, not recruiting

A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease (IRONMAN-II)

Coronary Artery Disease

China
Cordis Corporation

Completed

The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)

Coronary Stenosis
Cordis Corporation

Terminated

Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions (DECODE)

Peripheral Vascular Diseases

United States, China, Malaysia, India, Singapore
Seung-Jung Park
Johnson & Johnson; CardioVascular Research Foundation, Korea

Completed

Evaluation of Diabetic Effects on Clinical Outcomes After Sirolimus-Eluting Stents in the AsIAN Population (DESSIAN)

Coronary Artery Disease

Korea, Republic of
B. Braun Melsungen AG
Charite University, Berlin, Germany

Completed

Coroflex ISAR 2000 Registry (ISAR2000)

Coronary Artery Disease (CAD)

Germany, Spain, Malaysia
Beijing Chao Yang Hospital

Unknown

Safety and Efficacy Study of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction (STEMI) and Analysis of Current Status of Emergency PCI Green Channel for STEMI Patients in China (CREST-MI)

Myocardial Infarction | Coronary Artery Disease

China
JW Medical Systems Ltd

Completed

EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III) (CREDIT-III)

Coronary Artery Disease

China
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography Study

Coronary Artery Disease

Belgium, Netherlands
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis (ISAR-TEST-5)

Coronary Heart Disease

Germany
B. Braun Melsungen AG
Charite University, Berlin, Germany

Completed

Coroflex ISAR 2000 Extended Registry (ISAR2000 Extended)

Coronary Artery Disease (CAD)

Germany, Spain, Malaysia
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study (XIENCE V India)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

India
Abbott Medical Devices

Completed

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe (SPIRIT V)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Ireland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden
Abbott Medical Devices

Completed

SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

Myocardial Ischemia | Coronary Artery Disease | Vascular Disease | Coronary Artery Stenosis | Everolimus

Netherlands, Germany, Denmark
Yonsei University

Completed

Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension

Korea, Republic of
Xijing Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Tang-Du Hospital; General... and other collaborators

Recruiting

HELIOS China Registry: Evaluation of the HELIOS Stent in a 'Real-World' Patient Population

Coronary Artery Disease

China
Biotronik AG
Biotronik AG

Not yet recruiting

Safety and Clinical Performance of the DREAMS 3G Resorbable Magnesium Scaffold System (BIOMAG-II)

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Ischemic Heart Disease | Atherosclerosis, Coronary
Medtronic Vascular
Medtronic Bakken Research Center

Completed

Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent (RESOLUTE-AC)

Coronary Artery Disease

Switzerland
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

The First-In-Man Pilot Study of Firehawk

Coronary Heart Disease
Shandong Branden Med.Device Co.,Ltd
Shandong Rientech Medical Tech Co., Ltd.

Not yet recruiting

Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System

Coronary Heart Disease | Drug Eluting Stent
Medtronic Vascular

Active, not recruiting

RESOLUTE ONYX China Single Arm Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Active, not recruiting

Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study

Coronary Artery Disease | Antineoplastic Agents

China
Shanghai Bio-heart Biological Technology Co., Ltd.

Unknown

Galaxy Rapamycin Drug-Eluting Bioresorbable Coronary Stent System First-in-man Study

Heart Diseases
Chinese University of Hong Kong

Active, not recruiting

Time-trend Analysis of Clinical Characteristic and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Treated With PCI Over a 10-year Period (TQJ230)

Cardiovascular Diseases

Hong Kong
Medtronic Vascular

Completed

RESOLUTE China RCT (R-China RCT)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Completed

A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear) (Onyx ONE Clear)

Coronary Artery Disease

United States
Abbott Medical Devices

Terminated

ABSORB PHYSIOLOGY Clinical Investigation

Coronary Artery Disease

Netherlands, Australia, Singapore, China
Medtronic Vascular

Completed

RESOLUTE ONYX Post-Approval Study (ONYX PAS)

Coronary Artery Disease

United States, Belgium, France, Slovakia
Hospital Clinic of Barcelona

Completed

10-Years Follow-up of the EXAMINATION Trial (EXAMINAT10N)

Myocardial Infarction | Infarction | Necrosis | Cardiovascular Diseases | Vascular Diseases | ST Elevation Myocardial Infarction | Heart Disease

Spain, Italy, Netherlands
Deutsches Herzzentrum Muenchen
Bayerische Forschungsstiftung Muenchen

Completed

Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)

Coronary Disease

Germany
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Evaluation of New Specifications (38mm) of FirehawkTM in the Treatment of Coronary Heart Disease (Firehawk_38)

Coronary Heart Disease

China
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ I)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Australia, Germany, France, Switzerland, Netherlands, United Kingdom, Portugal, Belgium, Denmark
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Not yet recruiting

A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System

Coronary Artery Disease

China
Samsung Medical Center
Genoss Company Limited, Suwon, Korea

Recruiting

GENOSS Coronary Stent Clinical Trial

Ischemic Heart Disease

Korea, Republic of
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment (T-P)

Coronary Artery Disease | Coronary Stenosis

China
Shanghai MicroPort Medical (Group) Co., Ltd.

Unknown

Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial (FOCUS)

Coronary Heart Disease

China
Spanish Society of Cardiology

Completed

A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction: EXAMINATION Study

Myocardial Infarction

Spain, Italy, Netherlands
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United States, Australia, New Zealand, Germany
Flanders Medical Research Program

Completed

Drug Eluting Stents In The Critically Ischemic Lower Leg (DESTINY)

Peripheral Vascular Disease | Critical Limb Ischemia

Belgium, France, Germany
Scitech Produtos Medicos Ltda

Completed

A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus (INSPIRON)

Coronary Artery Disease

Brazil
University Hospitals, Leicester

Terminated

Transcutaneous Electrical Nerve Stimulation for Local Anaesthesia (TENS-LA)

Skin Graft | Donor Site Complication

United Kingdom
University of Avignon

Completed

Myocardial Function and Vitamin D Supplementation in Diabetes. (VitaDD)

Diabetes Complications | Vitamin D Deficiency | Vitamin D Supplementation | Myocardial Dysfunction

France
Beijing Tiantan Hospital

Recruiting

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial (DREAM-PRIDE)

Stroke | Intracranial Atherosclerotic Disease

China
Yonsei University

Completed

Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study

Multi-vessel Diseases, Angina

Korea, Republic of
Shanghai MicroPort Medical (Group) Co., Ltd.

Active, not recruiting

Firehawk Rapamycin Target Eluting Coronary Stent North American Trial (TARGET-IV_NA)

Coronary Artery Disease

United States, Denmark, Canada, Belgium, Netherlands

Search clinical trials for: Abluminus Sirolimus Eluting Stent System (ASES)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations